EFFICACY AND COST-EFFECTIVENESS OF A CLINIC-BASED AND TWO DIGITAL APPLICATIONS OF MCKENZIE THERAPY IN LONG-TERM LOW-BACK PAI

Phase 1

• Conditions: Musculoskeletal Diseases

• Registration Number: PACTR202208887892516
• Lead Sponsor: Chidozie Mbada

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-08-22
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Patients with Long term mechanical low back pain refers to back pain lasting not less than 3 months, of
musculoskeletal origin, and with symptoms varying with physical activity.
The standard McKenzie Institute Lumbar Spine Assessment Algorithm (MILSAA) was used to determine eligibility for participation.

Exclusion Criteria

Patients with positive history of red flags indicative of serious spinal pathology (i.e. those with complaints of dermatomal sensory loss, myotomal muscle weakness, and reduced lower limb reflexes).
Patients with any obvious spinal deformity or neurological disease.
Patients with pregnancy or previous spinal surgery.
Patients with previous experience of MDT extension protocol and underlying systemic or visceral disease or specific condition such as dementia, cognitive dysfunction, visual impairment, history of epilepsy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain Intensity

Secondary Outcome Measures

Name	Time	Method
Back Extension Muscles’ Endurance, Activity Limitation, Participation Restriction, Fear Avoidance Belief, Kinesiophobi, and General Health Status.